One year of Tysabri infusion improved working ability for relapsing-remitting multiple sclerosis (RRMS) patients in France, ...

Early treatment with Ocrevus may help protect the cerebellum from damage in people with multiple sclerosis, a study found.

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

Frank battled a degenerative disease in 'The Last of Us,' but the show never specified the name of his illness ...

At 67, marathon runner Jennifer Schubert-Akin is always told how inspiring she is for running at her age. But she does not ...

With the right strategies, you can ‘treat the treatment’ and use your MS medications reliably and successfully.

A directive in January from the National Institutes of Health aimed to reduce funding for many of the essential costs that ...

Researchers at Massachusetts General Hospital investigated how our brains process language during real-life conversations.

TGTX surges 200% in 2023 on Briumvi's MS success. With Q1'25 earnings ahead, see here for TGTX stock's sales trends, new ...

One continuing challenge is the need to suppress transplant patients' immune systems to prevent their bodies from rejecting ...

For Laurie Craigen, the realities of senior medical costs hit hard when her grandmother needed hospice care. "It was a stressful time for the family because we were trying to figure out how to ...

Mr. Malone is a 2nd generation financial advisor with over 40 years of family experience in wealth management. This combined with his deep entrepreneurial background he launched Malone Wealth in 2021.